Eli Lilly
Trade Eli Lilly 24 hours a day, five days a week on Robinhood.
Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.About LLY
Eli Lilly & Co. engages in the discovery, development, manufacture, and sale of pharmaceutical products. The firm's products consist of diabetes, oncology, immunology, neuroscience, and other products and therapies.
LLY Key Statistics
Stock Snapshot
With a market cap of 876.82B, Eli Lilly(LLY) trades at $927.47. The stock has a price-to-earnings ratio of 45.79 and currently yields dividends of 62.6%.
During the trading session on 2025-11-06, Eli Lilly(LLY) shares reached a daily high of $943.50 and a low of $916.26. At a current price of $927.47, the stock is +1.2% higher than the low and still -1.7% under the high.
Trading volume for Eli Lilly(LLY) stock has reached 895.46K, versus its average volume of 4.27M.
Over the past 52 weeks, Eli Lilly(LLY) stock has traded between a high of $955.46 and a low of $623.78.
Over the past 52 weeks, Eli Lilly(LLY) stock has traded between a high of $955.46 and a low of $623.78.
LLY News
(RTTNews) - Eli Lilly and Company (LLY) on Thursday announced positive results from a Phase 2 trial evaluating eloralintide in adults with obesity or overweight...
Eli Lilly (LLY) “announced positive results from a Phase 2 trial evaluating the safety and efficacy of eloralintide, an investigational once-weekly, selective a...
Eli Lilly on Thursday said it will start late-stage trials on its experimental amylin obesity drug next month after it showed encouraging results in a mid-stage...
Analyst ratings
77%
of 31 ratingsMore LLY News
Wall Street bounced back Wednesday after Tuesday's sharp selloff in AI-driven stocks, as investors bought the dip amid solid corporate earnings and growing sign...
Shareholders of Eli Lilly (Symbol: LLY) looking to boost their income beyond the stock's 0.6% annualized dividend yield can sell the January 2028 covered call a...
Shares of Novo Nordisk (NVO) fell on Wednesday morning after the Danish drugmaker agreed to a price deal under the U.S. Medicare program for the active ingredie...
Eli Lilly’s stock (LLY) is trending higher on Nov. 5 after archrival Novo Nordisk (NVO) lowered its growth outlook for its competing weight-loss drugs. Elevate...
Lilly's GLP-1 drug became the best-selling drug on Earth in the third quarter. Eli Lilly (LLY +1.13%) manufactures a drug called tirzepatide, a GLP-1 dual rece...
Elevate Your Investing Strategy: Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to...
Key Points Stanley Druckenmiller has a fantastic investing track record, delivering a double-digit average annual return over time. The billionaire sold artif...